Get the Stockscreener App
1.38
2.13%
-0.03
After Hours:
1.39
0.01
+0.72%
Cibus Inc stock is traded at $1.38, with a volume of 452.07K.
It is down -2.13% in the last 24 hours and down -57.28% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$1.41
Open:
$1.46
24h Volume:
452.07K
Relative Volume:
1.51
Market Cap:
$79.35M
Revenue:
$1.82M
Net Income/Loss:
$-267.63M
P/E Ratio:
-0.0684
EPS:
-20.1639
Net Cash Flow:
$-50.53M
1W Performance:
-8.61%
1M Performance:
-57.28%
6M Performance:
-50.36%
1Y Performance:
-85.99%
1-Day Range:
$1.38
$1.48
1-Week Range:
$1.38
$1.67
52-Week Range:
$1.38
$10.77
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.38 | 79.35M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.20 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
525.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
326.09 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
551.22 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
242.07 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Cibus and John Innes Centre announce ongoing collaboration with potential to revolutionise fertilizer use in farming - World Fertilizer
Financial Metrics Exploration: Understanding Cibus Inc (CBUS) Through Ratios - DWinneX
Two Sigma Investments LP Purchases New Holdings in Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus Slides on Alliance with John Innes Centre - Baystreet.ca
Cibus (CBUS) Expands Collaboration with John Innes Centre for Cr - GuruFocus
Cibus (CBUS) Expands Collaboration with John Innes Centre for Crop Innovation | CBUS Stock News - GuruFocus
Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming - The Manila Times
Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize ... - Leader-Telegram
Agricultural Breakthrough: Scientists Find Gene Mutation That Could Transform Farming Economics - Stock Titan
USDA-APHIS Designates Cibus's Herbicide Tolerance Canola Trait HT2 as Not Regulated - ISAAA.org
Millennium Management LLC Sells 15,409 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus, Inc. Announces Closing of $27.5 Million Public Offering | - GuruFocus
Cibus, Inc. Announces Closing of $27.5 Million Public Offering - The Manila Times
Cibus, Inc. Closes $27.5 Million Public Offering of Class A Common Stock - Nasdaq
Agricultural Biotech Cibus Secures $27.5M Investment to Advance Gene Editing Platform - Stock Titan
CBUS ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Cibus, Inc. Shareholders Who Lost Money - ACCESS Newswire
Hogs Look to New Week Following Friday Strength - The Globe and Mail
Jane Street Group LLC Takes Position in Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus says USDA designates HT2 as ‘not regulated’ under biotech regulations - Yahoo Finance
Nuveen Asset Management LLC Has $106,000 Position in Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus Canola Trait Gains USDA Non-Regulated Status By Investing.com - Investing.com South Africa
Cibus Announces Public Offering of Common Stock - TipRanks
Cibus Stock (CBUS) Plummets 30% on Public Offering Pricing - The Globe and Mail
Cibus stock rises on USDA deregulation of new canola trait By Investing.com - Investing.com Nigeria
Cibus stock rises on USDA deregulation of new canola trait - Investing.com Australia
Cibus Canola Trait Gains USDA Non-Regulated Status - Investing.com Australia
Cibus (CBUS) Gains USDA Approval for New Herbicide Tolerance Tra - GuruFocus
USDA Designates Cibus' Herbicide Tolerance Canola Trait HT2 as N - GuruFocus
USDA Designates Cibus' Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA's Biotechnology Regulations | CBUS Stock News - GuruFocus
USDA Designates Cibus' Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA's Biotechnology Regulations - The Manila Times
USDA Designates Cibus’ Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA’s ... - Leader-Telegram
USDA Designates Cibus’ Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA’s Biotechnology Regulations - TradingView
Breakthrough: USDA Greenlights Cibus Revolutionary Herbicide Resistance Technology for Global Canola Market - Stock Titan
Public market insider selling at Dye & Durham (DND) - The Globe and Mail
Cibus sets price for $27.5 million stock offering By Investing.com - Investing.com India
Stocks Dive After Key Announcements From Helius, Mullen, And Cibus - Finimize
Cibus Prices $27.5 Mln Public Offering To Advance Gene-Edited Rice Traits - Nasdaq
Canaccord Genuity lowers Cibus stock price target after equity raise By Investing.com - Investing.com South Africa
Canaccord Genuity lowers Cibus stock price target after equity raise - Investing.com
Cibus announces pricing of $27.5M public offering - MSN
Cibus announces pricing of $27.5 million public offering - MSN
Cibus stock plummets following offering price of $1.75 per share By Investing.com - Investing.com South Africa
Cibus stock plummets following offering price of $1.75 per share - Investing.com Australia
Cibus sets price for $27.5 million stock offering - Investing.com Australia
Cibus (CBUS) Prices Public Offering to Raise $27.5M | CBUS Stock News - GuruFocus
Cibus, Inc. Announces Pricing of $27.5 Million Public Offering - The Manila Times
Cibus, Inc. Announces Pricing of $27.5 Million Public Offering | - GuruFocus
Cibus, Inc. Announces Pricing of $27.5 Million Public Offering | CBUS Stock News - GuruFocus
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cibus Inc Stock (CBUS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Prante Gerhard | Director |
Feb 24 '25 |
Sale |
2.07 |
1,150 |
2,380 |
8,857 |
| Prante Gerhard | Director |
Feb 21 '25 |
Sale |
2.20 |
1,150 |
2,530 |
10,007 |
| Prante Gerhard | Director |
Feb 20 '25 |
Sale |
2.35 |
1,150 |
2,702 |
11,157 |
| Prante Gerhard | Director |
Feb 19 '25 |
Sale |
2.58 |
1,150 |
2,967 |
12,307 |
| Prante Gerhard | Director |
Feb 18 '25 |
Sale |
2.52 |
2,300 |
5,796 |
13,457 |
| Prante Gerhard | Director |
Feb 14 '25 |
Sale |
2.60 |
1,150 |
2,990 |
15,757 |
| Prante Gerhard | Director |
Feb 13 '25 |
Sale |
2.53 |
1,150 |
2,910 |
16,907 |
| Prante Gerhard | Director |
Feb 12 '25 |
Sale |
2.45 |
1,150 |
2,818 |
18,057 |
| Prante Gerhard | Director |
Feb 11 '25 |
Sale |
2.48 |
1,150 |
2,852 |
19,207 |
| Prante Gerhard | Director |
Feb 10 '25 |
Sale |
2.52 |
1,150 |
2,898 |
20,357 |
0.78%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):